According to the findings of TCGA, the area under the curve (AUC) for GABRD expression was 0.658, which indicated that GABRD has a significant predictive potential for the survival of COAD patients (Figure 4(c)). This evidence concerns the gene GABRD and colon adenocarcinoma.